BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6192767)

  • 1. [Effect of peplomycin by continuous infusion on Ehrlich carcinoma].
    Kato T; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):763-7. PubMed ID: 6192767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
    Sikic BI; Collins JM; Mimnaugh EG; Gram TE
    Cancer Treat Rep; 1978 Dec; 62(12):2011-7. PubMed ID: 87269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
    Ekimoto H; Takahashi K; Matsuda A; Umezawa H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma].
    Kanazawa H; Takahashi K; Hanazawa Y; Uchiyama S; Takahara T; Takahara M; Muto M; Kinehara M; Sato K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):775-80. PubMed ID: 2469396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K; Goto T; Fukushima M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
    Stoehr M; Friedel G; Engel P; Goerttler K; Futterman G
    Arzneimittelforschung; 1984; 34(4):451-4. PubMed ID: 6204650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental study on the combination therapy of cisplatin and peplomycin].
    Fujii M
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):512-9. PubMed ID: 2411899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
    Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
    Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic effect mechanism of cisplatin and peplomycin therapy--with special reference to the effect on cell cycle progression.
    Fujii M; Inuyama Y; Tanaka J; Takaoka T; Hosoda H
    Keio J Med; 1986 Jul; 35(3):188-97. PubMed ID: 2433490
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
    Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
    Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of continuous subcutaneous injection of peplomycin based on its pharmakinetics].
    Fujii M; Inuyama I; Masuno S; Tanaka T; Takaoka T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):1023-4. PubMed ID: 6191667
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice.
    Naresh RA; Udupa N; Devi PU
    Indian J Exp Biol; 1996 Aug; 34(8):764-72. PubMed ID: 8979482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The combined effect of peplomycin and X-ray irradiation].
    Munenaga Y
    Hiroshima Daigaku Shigaku Zasshi; 1984 Jun; 16(1):23-35. PubMed ID: 6206126
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effect of an antineoplastic agent (peplomycin) adsorbed on activated charcoal (PEP-AC)].
    Ekimoto H; Yamashita T; Takahashi K; Matsuda A; Nagahama F
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1380-6. PubMed ID: 6191713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of a continuous infusion with a daily bolus injection of bleomycin in a heterotransplanted human testicular cancer].
    Osieka R
    Arzneimittelforschung; 1984; 34(4):460-4. PubMed ID: 6204651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentration of peplomycin following intravenous infusion and subcutaneous infusion in patients with malignancies].
    Sampi K; Tari K; Kumai R; Satake I; Yashui H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2372-4. PubMed ID: 6208851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the combination of cisplatin and peplomycin on Ehrlich ascites carcinoma and on head and neck squamous cell carcinoma transplanted to nude mice].
    Mashino S
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):502-11. PubMed ID: 2411898
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.
    Nishimura C; Nishimura T; Tanaka N; Suzuki H
    J Antibiot (Tokyo); 1987 Dec; 40(12):1794-5. PubMed ID: 2448282
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced anti-cancer efficacy on lymph node metastasis using peplomycin adsorbed on small activated carbon particles.
    Ito M; Hagiwara A; Iwamoto A; Shimotsuma M; Yoneyama C; Sasabe T; Takahashi T
    Anticancer Drug Des; 1991 Jul; 6(3):169-77. PubMed ID: 1714736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion versus intermittent bolus injection of bleomycin in a human embryonal testicular cancer xenograft.
    Osieka R; Glatte P; Schmidt CG
    Cancer Treat Rep; 1984 May; 68(5):799-801. PubMed ID: 6202408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.